Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033517263> ?p ?o ?g. }
- W3033517263 endingPage "7185" @default.
- W3033517263 startingPage "7163" @default.
- W3033517263 abstract "Dermatologic disorders such as atopic dermatitis arise from genetic and environmental causes and are complex and multifactorial in nature. Among possible risk factors, aberrant immunological reactions are one of the leading etiologies. Immunosuppressive agents including topical steroids are common treatments for these disorders. Despite their reliability in clinical settings, topical steroids display side effects, typified by skin thinning. Accordingly, there is a need for alternate effective and well-tolerated therapies. As part of our efforts to investigate new immunomodulators, we have developed a series of JAK inhibitors, which incorporate novel three-dimensional spiro motifs and unexpectedly possess both excellent physicochemical properties and antidermatitis efficacy in the animal models. One of these compounds, JTE-052 (ent-60), also known as delgocitinib, has been shown to be effective and well-tolerated in human clinical trials and has recently been approved in Japan for the treatment of atopic dermatitis as the first drug among Janus kinase inhibitors." @default.
- W3033517263 created "2020-06-12" @default.
- W3033517263 creator A5003054696 @default.
- W3033517263 creator A5006258737 @default.
- W3033517263 creator A5008780435 @default.
- W3033517263 creator A5014243516 @default.
- W3033517263 creator A5015757564 @default.
- W3033517263 creator A5024740177 @default.
- W3033517263 creator A5030047214 @default.
- W3033517263 creator A5038007164 @default.
- W3033517263 creator A5043694398 @default.
- W3033517263 creator A5045449191 @default.
- W3033517263 creator A5050771157 @default.
- W3033517263 creator A5052797879 @default.
- W3033517263 creator A5056918029 @default.
- W3033517263 creator A5057605757 @default.
- W3033517263 creator A5059533769 @default.
- W3033517263 creator A5073264470 @default.
- W3033517263 creator A5074060371 @default.
- W3033517263 creator A5081183041 @default.
- W3033517263 creator A5082311842 @default.
- W3033517263 creator A5091348767 @default.
- W3033517263 date "2020-06-08" @default.
- W3033517263 modified "2023-10-09" @default.
- W3033517263 title "Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders" @default.
- W3033517263 cites W114839291 @default.
- W3033517263 cites W1578008264 @default.
- W3033517263 cites W1970308473 @default.
- W3033517263 cites W1971177351 @default.
- W3033517263 cites W1982385791 @default.
- W3033517263 cites W1986161286 @default.
- W3033517263 cites W1995629248 @default.
- W3033517263 cites W1999218213 @default.
- W3033517263 cites W2008810664 @default.
- W3033517263 cites W2021520444 @default.
- W3033517263 cites W2029275361 @default.
- W3033517263 cites W2032062642 @default.
- W3033517263 cites W2045189254 @default.
- W3033517263 cites W2060604544 @default.
- W3033517263 cites W2062458432 @default.
- W3033517263 cites W2065601509 @default.
- W3033517263 cites W2074274985 @default.
- W3033517263 cites W2083351855 @default.
- W3033517263 cites W2091635547 @default.
- W3033517263 cites W2093804554 @default.
- W3033517263 cites W2096095251 @default.
- W3033517263 cites W2101217991 @default.
- W3033517263 cites W2103299776 @default.
- W3033517263 cites W2116889630 @default.
- W3033517263 cites W2117926449 @default.
- W3033517263 cites W2119103976 @default.
- W3033517263 cites W2127073449 @default.
- W3033517263 cites W2141528038 @default.
- W3033517263 cites W2152877278 @default.
- W3033517263 cites W2166946754 @default.
- W3033517263 cites W2194790349 @default.
- W3033517263 cites W2332640360 @default.
- W3033517263 cites W2465799764 @default.
- W3033517263 cites W2516032265 @default.
- W3033517263 cites W2592451861 @default.
- W3033517263 cites W2607449794 @default.
- W3033517263 cites W2752127863 @default.
- W3033517263 cites W2767394258 @default.
- W3033517263 cites W2767881357 @default.
- W3033517263 cites W2781491897 @default.
- W3033517263 cites W2904559265 @default.
- W3033517263 cites W2950601752 @default.
- W3033517263 cites W2951192720 @default.
- W3033517263 cites W2994900772 @default.
- W3033517263 cites W2996140352 @default.
- W3033517263 cites W3004398344 @default.
- W3033517263 cites W4211026773 @default.
- W3033517263 cites W4211077900 @default.
- W3033517263 cites W4211145137 @default.
- W3033517263 cites W74634963 @default.
- W3033517263 doi "https://doi.org/10.1021/acs.jmedchem.0c00450" @default.
- W3033517263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32511913" @default.
- W3033517263 hasPublicationYear "2020" @default.
- W3033517263 type Work @default.
- W3033517263 sameAs 3033517263 @default.
- W3033517263 citedByCount "32" @default.
- W3033517263 countsByYear W30335172632020 @default.
- W3033517263 countsByYear W30335172632021 @default.
- W3033517263 countsByYear W30335172632022 @default.
- W3033517263 countsByYear W30335172632023 @default.
- W3033517263 crossrefType "journal-article" @default.
- W3033517263 hasAuthorship W3033517263A5003054696 @default.
- W3033517263 hasAuthorship W3033517263A5006258737 @default.
- W3033517263 hasAuthorship W3033517263A5008780435 @default.
- W3033517263 hasAuthorship W3033517263A5014243516 @default.
- W3033517263 hasAuthorship W3033517263A5015757564 @default.
- W3033517263 hasAuthorship W3033517263A5024740177 @default.
- W3033517263 hasAuthorship W3033517263A5030047214 @default.
- W3033517263 hasAuthorship W3033517263A5038007164 @default.
- W3033517263 hasAuthorship W3033517263A5043694398 @default.
- W3033517263 hasAuthorship W3033517263A5045449191 @default.
- W3033517263 hasAuthorship W3033517263A5050771157 @default.
- W3033517263 hasAuthorship W3033517263A5052797879 @default.